Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Proteomics. 2017 Mar;17(6):10.1002/pmic.201600228. doi: 10.1002/pmic.201600228

Figure 3.

Figure 3

Figure 3

Figure 3

The PI3K-AKT pathway from the KEGG mapper showing several upregulated proteins indicated in the pink based on the two fold change in the protein expression between LNCaP-95 androgen resistant and wildtype LNCaP prostate cancer cells (A). Immunohistochemistry showing overexpression of pAKT in castration resistant LNCaP xenograft tumors when compared to the LNCaP hormonal dependent tumors from the normal animal (B) and in LAPC4 xenograft and castration resistant LAPC4 xenograft model (C).